Home > Annual Financials > ALPA LABORATORIES

ALPA LABORATORIES Financial Statement Analysis
[BOM: 532878|NSE : ALPA]

The Revenues of ALPA LABORATORIES have decreased by -17.20% YoY .
The Earnings Per Share (EPS) of ALPA LABORATORIES has decreased by -10.75 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

ALPA LABORATORIES Last 5 Annual Financial Results
[BOM: 532878|NSE : ALPA]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹93 Cr₹112 Cr₹98 Cr₹86 Cr₹78 Cr
Expenses ₹85 Cr₹102 Cr₹90 Cr₹83 Cr₹77 Cr
Operating Profit (Excl OI) ₹8.08 Cr₹11 Cr₹7.70 Cr₹3.36 Cr₹1.14 Cr
Other Income ₹9.37 Cr₹11 Cr₹4.40 Cr₹2.91 Cr₹5.30 Cr
Interest ₹0.22 Cr₹0.22 Cr₹0.08 Cr₹0.20 Cr₹0.57 Cr
Depreciation ₹1.33 Cr₹1.66 Cr₹1.23 Cr₹3.17 Cr₹3.12 Cr
Profit Before Tax ₹16 Cr₹20 Cr₹11 Cr₹2.91 Cr₹2.76 Cr
Profit After Tax ₹13 Cr₹14 Cr₹7.25 Cr₹1.85 Cr₹1.01 Cr
Consolidated Net Profit ₹13 Cr₹14 Cr₹7.25 Cr₹1.85 Cr₹1.01 Cr
Earnings Per Share (Rs)₹5.98₹6.70₹3.44₹0.88₹0.48
PAT Margin (%)13.5412.557.432.161.30
ROE(%)9.8212.296.971.861.03
ROCE(%)12.1916.8110.423.093.26
Total Debt/Equity(x)0.020.050.000.000.02

Key Financials

Market Cap : ₹ 203.0 Cr
Revenue (TTM) : ₹ 114.3 Cr
Net Profit(TTM) : ₹ 18.0 Cr
EPS (TTM) : ₹ 8.6
P/E (TTM) : 11.3

Industry Peers & Returns1W1M1Y
ALPA LABORATORIES 5% 11.3% 57.5%
SUN PHARMACEUTICAL INDUSTRIES -0.1% -2.8% 50.3%
CIPLA 4.5% -3.1% 52.8%
DR REDDYS LABORATORIES 4.6% 1.4% 22.2%
ZYDUS LIFESCIENCES 3.1% -4.1% 80.4%
DIVIS LABORATORIES 4.7% 10.8% 18.1%
MANKIND PHARMA 2.7% 12.4% NA
TORRENT PHARMACEUTICALS 6.1% 5.3% 66.2%
LUPIN 3.1% -1.1% 127.4%


ALPA LABORATORIES Revenues
[BOM: 532878|NSE : ALPA]

Y-o-Y

-17.20 %

5 Yr CAGR

4.49 %

Years Revenues % Change
Mar2023 ₹93 Cr
-17.20
Mar2022 ₹112 Cr
15.08
Mar2021 ₹98 Cr
13.48
Mar2020 ₹86 Cr
10.23
Mar2019 ₹78 Cr -


ALPA LABORATORIES Operating Profit
[BOM: 532878|NSE : ALPA]

Y-o-Y

-24.26 %

5 Yr CAGR

63.00 %

Years Operating Profit % Change
Mar2023 ₹8.08 Cr
-24.26
Mar2022 ₹11 Cr
38.51
Mar2021 ₹7.70 Cr
129.35
Mar2020 ₹3.36 Cr
193.36
Mar2019 ₹1.14 Cr -

Operating Margins
Y-o-Y

-8.53 %

5 Yr CAGR

55.93 %

Years Operating Margin% % Change
Mar2023 8.69%
-8.53
Mar2022 9.5%
20.41
Mar2021 7.89%
102.31
Mar2020 3.9%
165.31
Mar2019 1.47% -

ALPA LABORATORIES Profit After Tax
[BOM: 532878|NSE : ALPA]

Y-o-Y

-10.71 %

5 Yr CAGR

87.78 %

Years Profit After Tax % Change
Mar2023 ₹13 Cr
-10.71
Mar2022 ₹14 Cr
94.45
Mar2021 ₹7.25 Cr
291.10
Mar2020 ₹1.85 Cr
83.10
Mar2019 ₹1.01 Cr -

PAT Margins
Y-o-Y

7.89 %

5 Yr CAGR

79.65 %

Years PAT Margin(%) % Change
Mar2023 13.54 %
7.89
Mar2022 12.55 %
68.91
Mar2021 7.43 %
243.98
Mar2020 2.16 %
66.15
Mar2019 1.3 % -

ALPA LABORATORIES Earnings Per Share (EPS)
[BOM: 532878|NSE : ALPA]

Y-o-Y

-10.75 %

5 Yr CAGR

87.87 %

Years EPS % Change
Mar2023 ₹5.98
-10.75
Mar2022 ₹6.70
94.77
Mar2021 ₹3.44
290.91
Mar2020 ₹0.88
83.33
Mar2019 ₹0.48 -

ALPA LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532878|NSE : ALPA]

Y-o-Y

-27.48 %

5 Yr CAGR

39.06 %

Years ROCE % Change
Mar2023 12.19%
-27.48
Mar2022 16.81%
61.32
Mar2021 10.42%
237.22
Mar2020 3.09%
-5.21
Mar2019 3.26% -

ALPA LABORATORIES Share Price vs Sensex

Current Share Price : ₹96.7
Current MarketCap: ₹ 203.0 Cr
Updated EOD on :Apr 25,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
ALPA LABORATORIES

5%

11.3%

57.5%

SENSEX

1.3%

2.6%

24%

ALPA LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ALPA LABORATORIES Financials


How the annual revenues of ALPA LABORATORIES have changed ?

The Revenues of ALPA LABORATORIES have decreased by -17.20% YoY .

How the Earnings per Share (EPS) of ALPA LABORATORIES have changed?

The Earnings Per Share (EPS) of ALPA LABORATORIES has decreased by -10.75 % YoY .